Growth Metrics

Bruker (BRKR) Operating Leases (2019 - 2025)

Bruker filings provide 7 years of Operating Leases readings, the most recent being $138.6 million for Q4 2025.

  • On a quarterly basis, Operating Leases rose 16.57% to $138.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $138.6 million, a 16.57% increase, with the full-year FY2025 number at $138.6 million, up 16.57% from a year prior.
  • Operating Leases hit $138.6 million in Q4 2025 for Bruker, up from $118.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $138.6 million in Q4 2025 to a low of $34.8 million in Q4 2022.
  • Median Operating Leases over the past 5 years was $98.5 million (2024), compared with a mean of $90.8 million.
  • Biggest five-year swings in Operating Leases: decreased 16.75% in 2022 and later surged 114.94% in 2023.
  • Bruker's Operating Leases stood at $41.8 million in 2021, then decreased by 16.75% to $34.8 million in 2022, then surged by 114.94% to $74.8 million in 2023, then skyrocketed by 58.96% to $118.9 million in 2024, then increased by 16.57% to $138.6 million in 2025.
  • The last three reported values for Operating Leases were $138.6 million (Q4 2025), $118.9 million (Q4 2024), and $120.5 million (Q3 2024) per Business Quant data.